Highlighted Articles - May 2012
Makowski et al report the success of their study, which set out to test the feasibility of using molecular magnetic resonance imaging to (MRI) to detect fibrin in vivo using a fibrin-targeted contrast-agent (FTCA). The relevance of this technique in allowing vulnerable plaques to be identified and quantified is outlined by the authors and discussed in an invited commentary by Clofent-Sanchez et al. However, although Clofent-Sanchez et al ...
Tovább